We are excited to announce the debut of the This Week in Policy and Medicine Podcast, a weekly series that brings you the latest insights and analyses from the intersection of healthcare policy and medical regulation. Hosted by Policymed.com, this podcast is designed to keep healthcare professionals, industry stakeholders, and policymakers informed about the dynamic changes in the life sciences sector.
In Our First Episode: “The Trump Presidency: Implications for Life Sciences”
The inaugural episode, titled “The Trump Presidency: Implications for Life Sciences,” delves deep into the potential impacts of Donald Trump’s presidency on the life sciences industry. With Trump confirmed as the President-elect, significant shifts are expected that could influence everything from pharmaceutical pricing strategies to regulatory oversight.
Featured Topics:
- Policy Shifts: What does a Trump presidency mean for drug pricing and healthcare regulations? We explore the anticipated changes and their implications for the life sciences sector.
- Expert Insights: Review what a Senior Counsel at the U.S. Health and Human Services Office of Inspector General (HHS-OIG), shared on new compliance priorities and the latest enforcement actions.
- Legal Developments: We cover the recent $450 million settlement by Teva Pharmaceuticals with the DOJ and a €462.6 million fine imposed by the European Commission for anti-competitive practices.
- Audit Findings: A discussion on the HHS OIG’s recent audit results for Humana Health Plan, Inc., revealing over $13 million in CMS overpayments.
The This Week in Policy and Medicine Podcast aims to provide you with expert perspectives and a comprehensive understanding of how upcoming and current policies can reshape the healthcare landscape. Our discussions are curated to aid professionals in navigating these changes effectively.
Tune in to Stay Ahead
Subscribe to the This Week in Policy and Medicine Podcast on Spotify or your favorite podcast platform to never miss an episode. Stay tuned and stay informed with Policymed.com as we bring you the forefront of healthcare policy and medical regulation.